8Barin F. Viruses and unconventional transmissible agents: update on transmission via blood. Transfus Clin Biol. 2000 , 7Suppl 1:5s.
9Pillonel J, Laperche S, Saura C, et al. Trends in residual of transfusion-transmitted viral infections in France between 1992and 2000. Transfusion, 2002 ,42(8) :966.
10Tobler LH, Tegtmeier G, Stramer SL, et al. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assay. Transfusion , 2000, 40(1):15.
4[2]Lackritz EM. Prevention of HIV transmission by blood transfusion in the developing world: achievements andcontinuing challenges. AIDS,1998, 12 (suppl A): 81～86
5[3]Nitita I, et al. Risk of transfusion - associated HIV transmission in Kinshasa, Zaire. AIDS, 1991, 5:437～439
6[4]Senge JN, Naygeie N. Lessens learned on trends in HIV/AIDS sentinel surveillance in Tanzannia. relying on constantly submitted data.12Th World AIDS Conference, Geneva, 1998
7[5]Christopher Anderson. AIDS scandal indicts French government blood test delayed to help French industry decision was made at the highest levels. Nature, 1991, 353:197
8[6]Leitman SF. Clinical implications of positive tests for antibodies to HIV in asymptomatic blood donors. N Engl J of Med, 1989, 321:917～924
9[7]Julian B. Prevalence of HTLV- Ⅲ antibody in American Blood Donors. N Engl J of Med, 1985, 313:384～385
10[8]Sawanpanyalert P. Donation deferral criteria for HIV positivity among blood donors in northern Thailand. Transfusion, 1996, 36: 242～249
